A Urine-Based Revolutionary Proteomic Platform Designed to Deliver Rapid Home and Point-of-Care Kits for Disease Diagnosis and Monitoring
A Urine-Based Revolutionary Proteomic Platform Designed to
Deliver Rapid Home and Point-of-Care Kits for Disease
Diagnosis and Monitoring
AccUrine is developing a non-invasive, urine-based proteomic platform for rapid, multiplexed biomarker detection. Our system combines proprietary algorithms that analyze thousands of protein fragments, custom-made antibodies optimized for urine conditions, and a lateral flow assay for fast, reliable results. Validated in patient urine samples, this innovative approach eliminates the need for blood draws or lab infrastructure, making diagnostics more accessible.
AccUrine is developing a non-invasive, urine-based proteomic platform for rapid, multiplexed biomarker detection.
AccUrine’s first product is a lateral flow test designed to identify bacterial infections in upper respiratory patients, bringing a groundbreaking, at-home diagnostic solution closer to commercialization.